Summit Global Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-36,238	Closed	-$1.67M	–	506
2023 Q3	$1.67M	Buy	36,238 +16,394	+83%	+$894K	0.11%	143
2023 Q2	$1.14M	Sell	19,844 -17,456	-47%	-$774K	0.08%	199
2023 Q1	$1.4M	Buy	37,300 +7,800	+26%	+$256K	0.11%	177
2022 Q4	$827K	Buy	29,500 +9,400	+47%	+$273K	0.07%	229
2022 Q3	$565K	Sell	20,100 -33,114	-62%	-$1.08M	0.05%	286
2022 Q2	$1.85M	Buy	53,214 +8,514	+19%	+$304K	0.16%	140
2022 Q1	$1.6M	Sell	44,700 -1,200	-3%	-$34K	0.12%	173
2021 Q4	$1.07M	Sell	45,900 -14,600	-24%	-$299K	0.07%	225
2021 Q3	$1.15M	Buy	60,500 +13,100	+28%	+$257K	0.09%	185
2021 Q2	$956K	Sell	47,400 -146	-0.3%	-$2.75K	0.06%	239
2021 Q1	$871K	Sell	47,546 -14,833	-24%	-$276K	0.06%	220
2020 Q4	$1.25M	Sell	62,379 -613	-1%	-$11.9K	0.13%	131
2020 Q3	$1.18M	Buy	62,992 +552	+0.9%	+$11.1K	0.12%	118
2020 Q2	$1.4M	Buy	62,440 +3,800	+6%	+$69.6K	0.16%	91
2020 Q1	$870K	Buy	58,640 +9,600	+20%	+$167K	0.13%	99
2019 Q4	$946K	Buy	49,040 +6,315	+15%	+$121K	0.1%	138
2019 Q3	$847K	Buy	+42,725	New	+$890K	0.1%	167